Patents Assigned to Innovative Therapies, Inc.
  • Patent number: 11007082
    Abstract: A foam laminate dressing includes a first distinct hydrophobic reticulated foam layer and an underlying second distinct hydrophilic layer bonded to the first layer and of substantially same length and width as the first distinct hydrophobic reticulated foam layer.
    Type: Grant
    Filed: July 23, 2014
    Date of Patent: May 18, 2021
    Assignee: Innovative Therapies Inc.
    Inventor: David M Tumey
  • Publication number: 20180207333
    Abstract: A therapeutic device having a hydrogel drape and a method of treatment using the same.
    Type: Application
    Filed: January 3, 2018
    Publication date: July 26, 2018
    Applicant: INNOVATIVE THERAPIES, INC.
    Inventors: David C. Vogel, David M. Tumey
  • Publication number: 20170028111
    Abstract: A new system for negative pressure wound therapy is described. The system includes a patient tube set connecting the wound dressing to the suction container. The patient tube set provides separate channels for applying suction to the wound site and sensing the therapeutic pressure at the wound site. A restrictor valve may also be included in order to introduce a small air leak into the system to prevent occlusions in the patient tube set.
    Type: Application
    Filed: July 29, 2016
    Publication date: February 2, 2017
    Applicant: INNOVATIVE THERAPIES, INC.
    Inventors: DAVID MALCOLM TUMEY, TIANNING XU, ALAN JOHN MARTIN, BRENT LEE BURCHFIELD, RAYMOND READE HARPHAM
  • Publication number: 20140088402
    Abstract: A smart phone is used to accomplish measurement of a wound surface area, when at least one flat marker device, which is a predefined reference, is placed near the wound and photographed by a smart phone.
    Type: Application
    Filed: December 17, 2012
    Publication date: March 27, 2014
    Applicant: INNOVATIVE THERAPIES, INC.
    Inventor: Tianning Xu
  • Patent number: 7837673
    Abstract: An apparatus includes a fluid permeable dressing and a cover membrane configured to extend over the fluid permeable dressing. A tube is coupled to the fluid permeable dressing and is configured to apply suction through the fluid permeable dressing. A fluid reservoir is coupled to the cover membrane, the fluid vessel including an inlet port configured to receive a fluid and an outlet port fluidically coupled to the fluid permeable dressing.
    Type: Grant
    Filed: September 29, 2005
    Date of Patent: November 23, 2010
    Assignee: Innovative Therapies, Inc.
    Inventor: Richard C. Vogel
  • Patent number: 7608066
    Abstract: An apparatus includes a pressure housing configured to be coupled to a vacuum source and a diaphragm sealingly coupled to the pressure housing. The diaphragm is configured to move in response to the vacuum source. A magnet is coupled to the diaphragm. A magnetic switch is disposed opposite the magnet and is configured to be actuated by the magnet when the magnet is a predetermined distance from the magnetic switch. The magnetic switch is configured to selectively actuate the vacuum source.
    Type: Grant
    Filed: February 9, 2006
    Date of Patent: October 27, 2009
    Assignee: Innovative Therapies, Inc.
    Inventor: Richard C. Vogel
  • Patent number: 7532953
    Abstract: An apparatus includes a fluid permeable dressing and a cover membrane configured to extend over the fluid permeable dressing. A tube is coupled to the fluid permeable dressing and is configured to apply suction through the fluid permeable dressing. A fluid reservoir is coupled to the cover membrane, the fluid vessel including an inlet port configured to receive a fluid and an outlet port fluidically coupled to the fluid permeable dressing.
    Type: Grant
    Filed: September 7, 2007
    Date of Patent: May 12, 2009
    Assignee: Innovative Therapies, Inc.
    Inventor: Richard C. Vogel
  • Patent number: 7012086
    Abstract: Chronic infection with retroviruses, such as HIV, induce a number of metabolic derangements. The present invention relates to a method for treating retrovirus-infected subjects with niacin compounds to reverse infection induced metabolic derangements.
    Type: Grant
    Filed: June 30, 2000
    Date of Patent: March 14, 2006
    Assignee: The Foundation For Innovative Therapies, Inc.
    Inventor: Michael F. Murray